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The coronavirus disease (COVID-19) pandemic has spread worldwide (1). The rapid transmission 
of the causative agent, severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2), has produced a 
high death toll, threatening health systems and creat-
ing huge challenges for governments and societies.
Until advances in the development and distri-
bution of vaccines or treatments reduce the risk for 
COVID-19 complications to levels permitting near-
normal day-to-day functioning, societies continue to 
require simple public health approaches to control 
pandemic spread, including mask use and social dis-
tancing. Several cohort studies in hospital settings 
have shown benefi ts of both interventions (2). How-
ever, in community settings, where these approaches 
have the greatest potential to limit viral spread and 
halt the pandemic, documented support for their use 
comes mostly from ecologic studies and, indirectly, 
from fi ndings related to previous pandemics of other 
coronaviruses. Only a few studies (3), including a ret-
rospective case-control study of asymptomatic con-
tacts (4), a randomized trial (5), and a study at sea (6), 
have evaluated their effectiveness against community 
transmission of SARS-CoV-2 on the basis of individu-
al-level exposure and outcome measurements. Their 
relevance remains embroiled in controversy. To help 
close this gap, we evaluated the association of mask 
use and social distancing with incident, symptomatic, 
laboratory-confi rmed SARS-CoV-2 infection in a pop-
ulation-based case-control study.
Methods
We conducted a population-based, case-control 
study in Porto Alegre, the capital of Rio Grande do 
Sul State, Brazil, which has an estimated popula-
tion of 1,483,771 (7). The ethics committee of the 
Hospital de Clínicas de Porto Alegre approved our 
study (approval no. 31499420.5.0000.5327), and the 
Brazilian National Ethics Committee (approval no. 
30415520.2.0000.5313) approved the accompanying 
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seroprevalence surveys. All participants gave prior 
informed consent, in written form by the controls and 
verbally for case-patients.
On March 19, 2020, state officials mandated school 
and nonessential business closure and travel restric-
tions and ordered citizens to stay at home unless go-
ing to essential services (8). On May 8, 2020, Porto 
Alegre’s mayor issued a series of orders and recom-
mendations for mask use. These mandates, with only 
slight alterations, remained in force in Porto Alegre 
throughout the period of this study. However, social 
distancing and mask use were not universally adopt-
ed; prominent leaders questioned their necessity and 
supported widely publicized gatherings, frequently 
without mask use.
We obtained case-patients from the Municipal 
Health Department, given that notification of CO-
VID-19 cases is mandatory. The list consisted of all 
persons (excluding healthcare professionals) who 
tested positive for SARS-CoV-2 by reverse transcrip-
tion PCR or antibody testing through June 19, 2020, 
in Porto Alegre. With rare exceptions, case-patients 
were receiving medical care, because testing during 
this period was limited and available only for symp-
tomatic persons. Cases were identified in hospitals 
and primary care settings. We then contacted persons 
>18 years of age whose date of symptom onset was on 
or after April 28, 2020. Before deeming a case-patient 
nonrespondent, we attempted >10 calls on different 
days at different hours, as well as attempting contact 
through short message service, WhatsApp, other so-
cial media, and physical mail. We excluded persons 
working in healthcare settings because our focus was 
community transmission. We also excluded deceased 
persons and persons who resided outside the mu-
nicipality. When the case-patient could not be inter-
viewed, we obtained responses from a proxy (i.e., a 
close contact, either a family member or caretaker).
Controls were the seronegative persons in 3 rep-
resentative community surveys of SARS-CoV-2 anti-
body prevalence in Porto Alegre conducted during 
May 9–11, May 23–25, and June 26–28, 2020 (9,10). 
For the surveys, 50 of Porto Alegre’s census tracts 
were selected with probability proportional to size. 
Within each, during each survey, 10 households were 
selected systematically; if no one was home or resi-
dents refused participation, we used the neighboring 
residence. A resident of each home was then selected 
at random for interview.
Controls underwent a brief interview, including 
questions on social distancing, mask use, and so-
ciodemographics. Seropositivity was determined by a 
point-of-care rapid antibody test (L.C. Pellanda et al., 
unpub. data, https://www.medrxiv.org/content/10
.1101/2020.05.06.20093476v1). For case-patients, we 
conducted telephone interviews by using the same 
questions applied in the surveys.
Trained interviewers queried case-patients and 
controls using standardized questionnaires: “Regard-
ing the social distancing recommended by health au-
thorities, that is, staying at home and avoiding contact 
with other people, how much do you think you have 
managed to do?” Reply choices were 1, very little; 2, 
little; 3, some; 4, a great deal; and 5, practically iso-
lated from everyone.
In response to “What has been your routine of 
activities?” participants opted among the following 
choices: 1, go out every day, all day, to work or other 
regular activity; 2, go out every day for some activ-
ity; 3, go out from time to time to shop and stretch 
my legs; 4, go out only for essential things like buying 
food; and 5, stay at home all the time. We created and 
categorized a social distancing score by summing re-
sponses to each of these questions when taken as an 
ordinal scale.
All case-patients were asked about mask use, but 
controls were asked about mask use only during the 
last seroprevalence survey. In response to “Do you 
use a mask when you leave home?” case-patients 
opted between yes and no and controls among yes, 
sometimes, and no. For modeling, we merged the re-
plies yes and sometimes. For case-patients and con-
trols, we defined income as mean head-of-household 
monthly income on the respondent’s census tract.
We calculated sample size by using an α of 0.05 
and 80% power: to detect an odds ratio of 2 would re-
quire 93 case-patients and 372 controls. We described 
continuous variables by mean (SD) or median (inter-
quartile range) and categorical variables by frequency 
(percentage). When information on household size 
was missing, we used the mean household size of 
the respondent’s census tract. Participants with other 
missing values were excluded from analyses. We in-
vestigated associations of social distancing and mask 
use through prespecified logistic regression analy-
ses. We defined the pandemic moment as the date of 
symptom onset for case-patients and as 10 days be-
fore the date of interview for controls. We performed 
all analyses by using the statistical software package 
R version 4.0.2 (11).
Results
Of all initial case-patients, after excluding deceased 
persons and those who were not part of the target 
population, 813 case-patients were eligible for contact 
(Figure 1). We established contact with 467 (57.4%) 
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and found an additional 184 ineligible. Of the remain-
ing 283 persons, 12 refused participation or provided 
incomplete social distancing information, leaving 
271 case-patients. We interviewed 237 (87.5%) di-
rectly and 34 (12.5%) by proxy. If the proportion of 
actual eligible case-patients among the 813 initially 
eligible persons was the same as among those con-
tacted (283/467), the 271 cases represent a response 
rate of 55.0% among those actually eligible. Compari-
son of the Municipal Health Department case data 
showed that case-patients in the final sample differed 
little from those not included in terms of sex (43.9% 
[95% CI 37.9%–50.0%] men among those included 
vs. 48.3% [95% CI 44.7%–58.6%] men among those 
excluded) and age (46.0 [95% CI 44.0–48.0] years for 
those included vs. 48.0 [95% CI 46.2–49.8] years for 
those excluded).
For controls, of 3,065 households approached, 
1,177 (38.4%) were vacant or without residents at 
home, residents refused in 388 (12.7%) households, 
and 4 seropositive persons were excluded; a total of 
1,496 (48.8%) potential controls were contacted (12). 
An additional 70 were <18 years old and data on race 
were missing for 30, leaving 1,396 (45.5%) for analy-
ses. Comparison of controls in the final sample with 
the 30 persons for whom data were missing demon-
strated they were also similar in sex (38.5% [95% CI 
35.9%–41.0%] men for final controls vs. 36.7% [95% CI 
21.9%–54.5%] men for those with data missing) and 
age (49.7 [95% CI 48.8–50.6] for final controls vs. 52.3 
[95% CI 44.1–60.5] years for those with data missing).
Our controls were more frequently women and 
were somewhat older than the average of the adult 
population of Porto Alegre (Table 1) (13). Case-pa-
tients, compared to controls, were more frequently 
men, Black, and younger; had a lower level of educa-
tion; and lived in larger households (Table 2). Case-
patients were less likely to adhere to social distanc-









Characteristic Porto	Alegre,	% Controls,	% 
Sex 
  
 M 47.8 38.5 
 F 52.2 61.5 
Age	group,	y 
  
 18–29 20.2 15.5 
 30–39 18.4 17.9 
 40–49 15.8 16.1 
 50–59 18.8 17.6 
 >60 26.8 33.0 
Race 
  
 White 75.3 75.4 
 Nonwhite 24.7 24.6 
 
RESEARCH
case-patients more frequently practiced least (16.2% 
vs. 7.2% for controls) or little (26.6% vs. 15.5% for con-
trols) social distancing. Mask use was commonly re-
ported. After we excluded those reporting staying at 
home all the time, only 5 (1.2%) controls and 14 (7.1%) 
case-patients reported not using masks when out.
We compared the temporal distribution of symp-
tom onset of case-patients and the 3 interview periods 
for controls (Figure 2). On average, symptom onset in 
case-patients was slightly less than a week before the 
interview date of controls (Table 2).
In crude analyses (Table 3, model 1), moderate or 
high adherence to social distancing and being practi-
cally isolated from everyone all reduced risk for infec-
tion. Multiple adjustments (models 2 and 3) produced 
little change. In model 3, those with moderate adher-
ence to social distancing were 72% (OR 0.28, 95% CI 
0.16–0.49) and those with high adherence 75% (OR 
0.25, 95% CI 0.15–0.42) less likely to become infected. 
Persons who reported they were practically isolated 
from everyone were 59% (OR 0.41, 95% CI 0.24–0.70) 
less likely to become infected. When we excluded 
proxy interviews (model 4), the association of being 
practically isolated from everyone became stronger 
(OR 0.34, 95% CI 0.20–0.60).
In similar models (Table 3), lesser activity of any 
degree reduced the odds of infection compared to 
leaving home daily for the whole day. Relatively 
little confounding was present, and in models ad-
justed for all covariates, going out for some activi-
ties every day reduced odds by 74% (OR 0.26, 95% 
CI 0.13–0.49), going out from time to time reduced 
odds by 61% (OR 0.39, 95% CI 0.24–0.61), and going 
out just for essential activities reduced odds by 75% 
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Table 2. Sociodemographic	and	social	distancing	data	of	case-patients	and	controls,	Porto	Alegre,	Brazil,	April–June	2020* 
Characteristic Case-patients,	n	=	271 Controls,	n	=	1,396 
Sex   
 M 119	(43.9) 537	(38.5) 
 F 152	(56.1) 859	(61.5) 
Mean	age,	y,	SD 46.0	17.2 49.7	17.5 
Education 
  
 University 98	(36.2) 722	(51.7) 
 High	school	complete 88	(32.5) 388	(27.8) 
 High	school	incomplete 85	(31.4) 286	(20.5) 
Race 
  
 White 197	(72.7) 1053	(75.4) 
 Mixed	race 35	(12.9) 182	(13.0) 
 Black 36	(13.3) 149	(10.7) 
 Other 3	(1.1) 12	(0.9) 
Household	size	SD 2.9	1.2† 2.5	1.4 
Monthly income, Brazilian real, head of household‡ 1,575	(IQR	965–3,365) 2,205	(IQR	1,089–3,390) 
Epidemiologic	week	SD 21.9	1.6 21.0	2.9 
Adherence	to	social	distancing 
  
 Very	little 32	(11.8) 56	(4.0) 
 Little 32	(11.8) 81	(5.8) 
 Moderate—some 43	(15.9) 260	(18.6) 
 High—a	great	deal 88	(32.5) 651	(46.6) 
 Practically	isolated	from	everybody 76	(28.0) 348	(24.9) 
Daily	routine 
  
 Go	out	every	day,	all	day,	to	work	or	other	regular	activity 118	(43.5) 251	(18.0) 
 Go	out	every	day	for	some	activity 12	(4.4) 102	(7.3) 
 Go	out	from	time	to	time	to	shop	and	stretch	my	legs 30	(11.1) 192	(13.8) 
 Go	out	only	for	essential	things	like	buying	food 74	(27.3) 696	(49.9) 
 Stay	at	home	all	the	time 37	(13.7) 155	(11.1) 
Social	distancing	score	SD 6.2	2.5 7.1	2.0 
Social	distancing 
  
 Least 44	(16.2) 100	(7.2) 
 Little 72	(26.6) 216	(15.5) 
 Much 98	(36.2) 729	(52.2) 
 Most 57	(21.0) 351	(25.1) 
Mask	use§   
 No 14	(7.1) 5	(1.2) 
 Sometimes NA 10	(2.4) 
 Always 184	(92.9) 405	(96.4) 
*Values	are	no.	(%)	except	as	indicated.	IQR,	interquartile	range;	NA,	not	applicable. 
†Excluding 4 case-patients	living	in	nursing	homes. 





(OR 0.25, 95% CI 0.18–0.36). After we excluded proxy 
interviews (model 4), staying home all the time also 
provided a major reduction in odds (OR 0.25, 95% 
CI 0.13–0.44).
When these 2 measures were joined in a categori-
cal summary measure of social distancing (Table 3), 
practicing much distancing reduced the adjusted 
odds of becoming infected by 67% (OR 0.33, 95% 
CI 0.22–0.52) and most distancing reduced odds by 
62% (OR 0.38, 95% CI 0.23–0.62), in comparison to 
least distancing. After excluding proxy interviews, 
the association became graded; odds were 73% lower 
(OR 0.27, 95% CI 0.16–0.46) among persons who prac-
ticed the most social distancing.
Because information on mask use was only ob-
tained during the third seroprevalence survey, we 
compared use for the 464 controls in this survey 
with 229 case-patients of a similar pandemic moment 
(symptom onset <10 days before the second survey). 
Considering all those with mask data during this 
period, crude analyses demonstrated that mask use 
reduced odds of infection by 88% (OR 0.12, 95% CI 
0.04–0.30), and after adjustments, including the sum-
mary distancing score (Table 4, model 3), by 90% 
(OR 0.10, 95% CI 0.03–0.25). No interaction was seen 
between mask use and social distancing (OR 0.96, 
95% CI 0.60–1.58). The association was similar in the 
restricted sample, which removed those who report-
ed staying home all the time (87%; OR 0.13, 95% CI 
0.04–0.36) and, in addition, when proxy respondents 
were removed (88%; OR 0.12, 95% CI 0.04–0.35). In 
a sensitivity analysis in which “sometimes” mask 
use was joined with “no” rather than with “always,” 
mask use reduced odds of infection (model 3) by 64% 
(OR 0.36, 95% CI 0.17–0.74).
Finally, when we adjusted social distancing asso-
ciations for mask use in an analysis limited to controls 
from the third survey and cases of similar pandemic 
moment, we found little change in associations with 
social distancing. There was 50% (OR 0.51, 95% CI 
0.27–0.93) lesser risk for infection with little social dis-
tancing, 67% (OR 0.33, 95% CI 0.19–0.60) with much 
social distancing, and 59% (OR 0.41, 95% CI 0.21–0.80) 
with the most social distancing.
Discussion
In this population-based case-control study of COV-
ID-19 conducted during a period of low-level to mid-
level viral transmission in a major city in Brazil, mask 
use and adherence to social distancing resulted in 
major protection against symptomatic SARS-CoV-2 
infection. Even after adjusting for various risk factors, 
adults who reported moderate or greater adherence 
to distancing recommendations reduced their odds 
of infection by one half to two thirds, and those who 
reported using masks when out reduced their risk by 
87%. Because we excluded persons in healthcare set-
tings, our findings directly address the use of these 















Evidence supporting the use of nonpharmaco-
logic public health measures to slow viral spread of 
SARS-CoV-2 in communities has come mainly from 
ecologic studies documenting large inverse associ-
ations between greater use of these measures and 
viral spread (14–17). Evidence based on individu-
al-level analyses, which come almost exclusively 
from studies of severe acute respiratory syndrome 
(SARS) and Middle East respiratory syndrome or 
from investigations in hospitals, have findings 
similar to ours: that risk approximately doubled 
with each additional meter of proximity to known 
infected persons, and that mask use reduced risk 
for transmission by 85% (OR 0.15, 95% CI 0.07–0.34) 
(2). Similar, although weaker, protection in a SARS-
CoV-2 outbreak in a specific setting (the USS Roos-
evelt aircraft carrier) was found with greater use of 
face coverings (OR 0.30, 95% CI 0.17–0.52), avoid-
ance of common areas (OR 0.56, 95% CI 0.37–0.86), 
and increased distance from others (OR 0.52, 95% 
CI 0.34–0.79) (6).
Very few individual-level studies have been 
reported on the effect of these measures on com-
munity transmission of SARS-CoV-2 (18). A case-
control study of asymptomatic contacts in Thailand 
documented a risk reduction of 77% with mask use 
and 85% with distancing greater than 1 meter (4), 
and a study from Wuhan, China, showed mask use 
at home during the lockdown provided protection 
(19). An additional report ascertained that greater 
mask use reduced risk for predicted COVID-19 by 
63% (S. Kwon et al., unpub. data, https://www.
medrxiv.org/content/10.1101/2020.11.11.2022950
0v1). Finally, a cross-sectional study from Vermont, 
USA, with only 10 cases showed some protection in 
crude analyses (20).
A randomized trial in Denmark (5) that sug-
gested lower, nonsignificant protection (OR 0.82, 
95% CI 0.54–1.23) of mask use, although based on 
a potentially stronger design, had major methodo-
logic problems (21,22). First, mask use was limited; 
only 46% reported full adherence. Second, 84% of 
outcomes were detected by antibody testing, lead-
ing an editorial accompanying the publication (21) 
to note that, given the extremely low incidence of 
cases, “all of the antibody-positive results in both in-
tervention and control groups could have been false 
positives.” When the study analyzed the subset of 
healthcare-diagnosed cases (15 participants), masks 
provided a greater, though not statistically signifi-
cant, protection (OR 0.52, 95% CI 0.18–1.53). Third, 
the trial’s short study periods (1 month), coupled 
with low antibody test sensitivity in early disease 
(30% <7 days and 72% during days 8–14) (23), could 
have resulted in the inclusion during the initial 2 
weeks of case-patients who had contacted the dis-
ease before trial initiation. Similarly, during the final 
2 weeks of the study period, some infections could 
have been missed by antibody testing, also not being 
detected by home-based reverse transcription PCR 
of uncertain sensitivity at close-out. Finally, because 
the intervention did not include face mask use by 
other household members, some cases could have 











 Little 0.69	(0.38–1.26) 0.72	(0.39–1.32) 0.65	(0.35–1.21) 0.65	(0.34–1.22) 
 Moderate	(Some) 0.29	(0.17–0.50) 0.30	(0.17–0.52) 0.28	(0.16–0.49) 0.30	(0.17–0.53) 
 High	(A	great	deal) 0.24	(0.15–0.39) 0.28	(0.17–0.47) 0.25	(0.15–0.42) 0.26	(0.16–0.44) 
 Practically	isolated	from	everyone 0.38	(0.23–0.63) 0.44	(0.26–0.75) 0.41	(0.24–0.70) 0.34	(0.20–0.60) 
What	has	been	your	routine	of	activities?# 
 
 Go	out	every	day	for	some	activity 0.25	(0.13–0.46) 0.27	(0.14–0.50) 0.26	(0.13–0.49) 0.25	(0.12–0.48) 
 Go	out	from	time	to	time	for	some	activity 0.33	(0.21–0.51) 0.38	(0.24–0.59) 0.39	(0.24–0.61) 0.38	(0.23–0.60) 
 Go	out	just	for	essential	activities 0.23	(0.16–0.31) 0.24	(0.17–0.34) 0.25	(0.18–0.36) 0.25	(0.18–0.35) 
 Stay	at	home	all	the	time 0.51	(0.33–0.77) 0.51	(0.31–0.80) 0.48	(0.29–0.77) 0.25	(0.13–0.44) 
Social	distancing	summary	classification** 
 
 Little 0.76	(0.49–1.19) 0.80	(0.51–1.26) 0.73	(0.46–1.16) 0.75	(0.47–1.20) 
 Much 0.31	(0.20–0.46) 0.35	(0.23–0.54) 0.33	(0.22–0.52) 0.33	(0.22–0.52) 










tions of the trial to current community settings, in 
which a greater fraction of other household mem-
bers would also be using masks when out.
Our study provides estimates for easily interpre-
table measures—percentage effectiveness of social 
distancing and masking in protecting against infec-
tion—in the general community, the setting of great-
est relevance for controlling the pandemic. The study 
occurred during a period of low to moderate trans-
mission. Rio Grande do Sul State seroprevalence data 
suggest that ≈0.5% of the population became infected 
and 57 (3.8/100,000 population) COVID-19 deaths 
occurred in Porto Alegre during our ≈2-month study 
period (24).
The first potential limitation of our study was 
that response rates for case-patients (55.0%) and 
controls (45.5%) were low, and differential nonpar-
ticipation could introduce selection bias. Whereas 
not being available to participate could be associated 
with less social distancing, additional factors could 
explain the low response. Among case-patients, 
the frequent address changes identified when con-
tact was achieved suggest that many case-patients 
on the initial list were ineligible because they were 
nonresidents who had furnished a false address to 
gain access to care. In addition, telemarketing and 
telephone scams lead many to ignore calls from un-
known numbers. Of note, however, if these persons 
did not respond because they were away from their 
landline telephones, their inclusion would have re-
sulted in even stronger associations. Among con-
trols, refusal to participate was uncommon (12.7%); 
vacant residences were the main cause of nonre-
sponse. Although interviews occurred on weekends, 
the limited attempts made to locate absent residents 
could have resulted in enrollment of controls who 
were more likely to practice social distancing. If so, 
this factor could have resulted in an overreport of 
the true effect. However, other reasons could ex-
plain the high vacancy rate, such as residents visit-
ing vacation homes or relatives; residents, especially 
in apartments or other housing with restricted ac-
cess, not responding to strangers; and residences 
being temporarily vacant. Our adjustment for age, 
sex, and other covariates could have at least partially 
controlled for these differential responses.
Second, some exposure misclassification was pos-
sible, because questions about mask use and social 
distancing were unvalidated and limited in detail, 
having been taken from the community serology sur-
vey providing the controls. As such, we were unable 
to address differences in protection when indoors, 
outdoors, or indoors in specific settings.
Third, full adjustment for pandemic moment in 
analyses of mask use was not possible, because con-
trols with data on mask use were all interviewed in 
a period shortly after case-patients began experienc-
ing symptoms. However, given that this period was 
short and followed mandated mask use, a temporal 
trend in mask use would probably have been small 
and thus have had little effect on our estimates.
Fourth, controls could include persons who had 
received a misdiagnosis of false-negative. However, 
given low seroprevalence and our test’s 86.4% sen-
sitivity and 99.6% specificity (L.C. Pellanda, unpub. 
data), we estimate that misdiagnosis would likely 
have occurred in only 1 control.
Fifth, as the serology survey did not include oc-
cupation, we could not exclude healthcare workers 
among controls. Because healthcare workers would 
likely adhere to greater social distancing and mask 
use, their inclusion among controls could have falsely 
strengthened our findings. However, only ≈5% of the 
workforce in Brazil are healthcare workers (25), so we 
do not believe that their inclusion produced an ap-
preciable error. In addition, errors because of lack of 
control for unmeasured confounding (e.g., from other 
occupational or residual socioeconomic differences or 
from recent travel) are always possible.
Sixth, a specific finding—lesser protection of those 
who reported being practically isolated from every-
one and those who reported staying at home all the 
time (Table 3, model 3)—could weaken confidence in 
our social distancing results. However, as suggested 
by the additional analysis removing proxy responses 
(model 4), the lack of a graded dose-response in the 
model 3 associations could have been because of the 
greater risk level of case-patients who reported they 
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Table 4. Association	of	mask	use	with	severe	acute	respiratory	syndrome	coronavirus	2	infection,	Porto	Alegre,	Brazil,	April–June	2020 
Sample 
Odds	ratio	(95%	CI) 
Model	1* Model 2† Model 3‡ 
All,	n	=	693 0.12	(0.04–0.30) 0.10	(0.03–0.25) 0.10	(0.03–0.25) 
Restricted	sample,	n	=	618§ 0.16	(0.05–0.42) 0.12	(0.04–0.35) 0.13	(0.04–0.36) 
Restricted	sample,	proxies	removed,	n	=	609¶ 0.16	(0.05–0.44) 0.12	(0.03–0.34) 0.12	(0.04–0.35) 
*Crude	model. 
†Model 1 with addition of sex, age, educational	attainment,	race,	income,	and	household	size. 





were isolated but actually resided in assisted living.
Finally, application of our findings to settings 
with circulating virus variants or to persons who 
have received vaccination can only be speculated. 
In the case of circulating variants, risk for infection 
among those distancing and using masks will prob-
ably be greater, but risk among those not distancing 
or not using masks will also be greater. In the case 
of vaccination, however, risk for infection would be 
lower for all. We know of no a priori reason, however, 
to presume that the relative protection of distancing 
and mask use in these settings would be either lesser 
or greater than we report.
The primary strength of our report is that, as 
a population-based study, it avoids the risk for se-
lection bias typical of less representative designs. 
It is sufficiently large to permit precise confidence 
intervals for our estimates of the benefit of protec-
tive measures. Furthermore, because our cases 
were detected at a time when testing was limited to 
symptomatic persons seeking care, the protection 
we found was against becoming a clinically relevant 
case. Finally, and perhaps most vital, our findings 
are based on individual-level analyses and thus per-
mit estimation of percent reduction of risk, a direct 
and simple way to communicate the magnitude of 
individual protection afforded by these simple pub-
lic health measures.
Given the hurdles faced in vaccine production, 
distribution, and acceptance, and the increasing 
emergence of virus variants, mass vaccination is un-
likely to suffice to control the pandemic in the near 
future in many parts of the world. During this period 
and continuing into the future phase of maintaining 
viral control, simple public health measures, princi-
pally social distancing and mask use, will remain cru-
cial options to minimize viral spread. 
In conclusion, we found that social distancing and 
mask use while away from home provided major pro-
tection against symptomatic SARS-CoV-2 infection. 
Our easily grasped and generalizable estimates of 
protection against transmission lend support to pre-
vious, frequently less direct, assessments. Our find-
ings support the contention that greater use of simple 
public health measures in the community provides 
major protection against symptomatic infection.
This article was preprinted at https://papers.ssrn.com/
sol3/papers.cfm?abstract_id=3731445.
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Coronavirus
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Humans have spent eons imagin-
ing—and experiencing—outbreaks 
of disease. Now that the COVID-19 
pandemic has reached our doorstep, 
it’s jarring to think about how this 
virus is eerily different from the pan-
demics of popular imagination. 
In this EID podcast, Dr. Elana Osen, 
a specialty registrar at St. George’s 
University Hospital in London, reads 
a poem she wrote about her experi-
ence of the COVID-19 pandemic. 
